Recombinant AKT1 (Prognostic Marker for Neuroendocrine Tumors) Antibody

Biorbyt

Recombinant AKT1 (Prognostic Marker for Neuroendocrine Tumors) Antibody

10

Positive Control: MCF-7 cells. PDGF-treated NIH/3T3 cells. HeLa cell lysates. Human pancreas or cervical carcinoma. Western Blot (1-2ug/ml); ,Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT),(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined. IHC, WB

Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Monoclonal

rAKT1/2491

1.0 mg/ml

Unconjugated

AKT1

AKT serine/threonine kinase 1

AKT; AKT1m; PKB; PKB alpha; PKB-ALPHA; PRKBA; protein kinase B alpha; proto-oncogene c-Akt; RAC; rac protein kinase alpha; RAC-ALPHA; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; serine-threonine protein kinase; v-akt murine thymoma viral oncogene homolog 1; v-akt murine thymoma viral oncogene-like protein 1

Mouse

IgG1

RAC-alpha serine/threonine-protein kinase

Recombinant AKT1 (Prognostic Marker for Neuroendocrine Tumors) Antibody

Human

-20°C,2°C to 8°C

12352203